DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bayer CM, Beckmann MW, Fasching PA.
Updates on the role of receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand/osteoprotegerin pathway in breast cancer risk and treatment.
Curr Opin Obstet Gynecol 2017;
29: 4-11
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.